Logo image of NLS

NAUTILUS INC (NLS) Stock Fundamental Analysis

NYSE:NLS - New York Stock Exchange, Inc. - US63910B1026 - Common Stock - Currency: USD

0.8204  +0.08 (+11.2%)

After market: 0.85 +0.03 (+3.61%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NLS. NLS was compared to 30 industry peers in the Leisure Products industry. While NLS seems to be doing ok healthwise, there are quite some concerns on its profitability. NLS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

NLS had negative earnings in the past year.
NLS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NLS reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: NLS reported negative operating cash flow in multiple years.
NLS Yearly Net Income VS EBIT VS OCF VS FCFNLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

NLS has a Return On Assets of -35.77%. This is in the lower half of the industry: NLS underperforms 79.41% of its industry peers.
The Return On Equity of NLS (-84.89%) is worse than 76.47% of its industry peers.
Industry RankSector Rank
ROA -35.77%
ROE -84.89%
ROIC N/A
ROA(3y)-17.6%
ROA(5y)-18.09%
ROE(3y)-48.86%
ROE(5y)-48.19%
ROIC(3y)N/A
ROIC(5y)N/A
NLS Yearly ROA, ROE, ROICNLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

NLS's Gross Margin of 19.60% is on the low side compared to the rest of the industry. NLS is outperformed by 88.24% of its industry peers.
In the last couple of years the Gross Margin of NLS has declined.
NLS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.28%
GM growth 5Y-18.44%
NLS Yearly Profit, Operating, Gross MarginsNLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

4

2. Health

2.1 Basic Checks

NLS does not have a ROIC to compare to the WACC, probably because it is not profitable.
NLS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NLS has been increased compared to 5 years ago.
Compared to 1 year ago, NLS has a worse debt to assets ratio.
NLS Yearly Shares OutstandingNLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
NLS Yearly Total Debt VS Total AssetsNLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

An Altman-Z score of 1.84 indicates that NLS is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.84, NLS is doing worse than 61.76% of the companies in the same industry.
NLS has a debt to FCF ratio of 1.35. This is a very positive value and a sign of high solvency as it would only need 1.35 years to pay back of all of its debts.
NLS has a Debt to FCF ratio of 1.35. This is in the better half of the industry: NLS outperforms 70.59% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that NLS is not too dependend on debt financing.
NLS has a Debt to Equity ratio of 0.24. This is in the better half of the industry: NLS outperforms 61.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.35
Altman-Z 1.84
ROIC/WACCN/A
WACC11.43%
NLS Yearly LT Debt VS Equity VS FCFNLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.99 indicates that NLS should not have too much problems paying its short term obligations.
NLS has a Current ratio (1.99) which is in line with its industry peers.
A Quick Ratio of 1.08 indicates that NLS should not have too much problems paying its short term obligations.
NLS has a Quick ratio (1.08) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.08
NLS Yearly Current Assets VS Current LiabilitesNLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

3

3. Growth

3.1 Past

NLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.92%, which is quite impressive.
NLS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -40.47%.
Measured over the past years, NLS shows a decrease in Revenue. The Revenue has been decreasing by -6.73% on average per year.
EPS 1Y (TTM)47.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.19%
Revenue 1Y (TTM)-40.47%
Revenue growth 3Y-2.49%
Revenue growth 5Y-6.73%
Sales Q2Q%-23.84%

3.2 Future

NLS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.62% yearly.
NLS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.08% yearly.
EPS Next Y80.64%
EPS Next 2Y35.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.27%
Revenue Next 2Y5.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NLS Yearly Revenue VS EstimatesNLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
NLS Yearly EPS VS EstimatesNLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2

2

4. Valuation

4.1 Price/Earnings Ratio

NLS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NLS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NLS Price Earnings VS Forward Price EarningsNLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of NLS indicates a rather cheap valuation: NLS is cheaper than 97.06% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.42
EV/EBITDA N/A
NLS Per share dataNLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

NLS's earnings are expected to grow with 35.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.62%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NAUTILUS INC

NYSE:NLS (10/31/2023, 8:26:50 PM)

After market: 0.85 +0.03 (+3.61%)

0.8204

+0.08 (+11.2%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)08-09 2023-08-09/amc
Earnings (Next)11-08 2023-11-08/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners3.88%
Ins Owner Change0%
Market Cap29.14M
Analysts74.29
Price Target2.04 (148.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)31.45%
Min EPS beat(2)-3.09%
Max EPS beat(2)65.99%
EPS beat(4)2
Avg EPS beat(4)13.84%
Min EPS beat(4)-26.01%
Max EPS beat(4)65.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.4%
Min Revenue beat(2)-7.9%
Max Revenue beat(2)18.71%
Revenue beat(4)1
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-7.9%
Max Revenue beat(4)18.71%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.19%
EPS NY rev (1m)0%
EPS NY rev (3m)29.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF 2.42
P/OCF 1.3
P/B 0.49
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)-1.5
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)0.34
FCFY41.34%
OCF(TTM)0.63
OCFY77.09%
SpS7.71
BVpS1.66
TBVpS1.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.77%
ROE -84.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.6%
FCFM 4.4%
ROA(3y)-17.6%
ROA(5y)-18.09%
ROE(3y)-48.86%
ROE(5y)-48.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.28%
GM growth 5Y-18.44%
F-Score4
Asset Turnover1.95
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.35
Debt/EBITDA N/A
Cap/Depr 87.18%
Cap/Sales 3.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.08
Altman-Z 1.84
F-Score4
WACC11.43%
ROIC/WACCN/A
Cap/Depr(3y)122.77%
Cap/Depr(5y)113.7%
Cap/Sales(3y)2.79%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.19%
EPS Next Y80.64%
EPS Next 2Y35.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.47%
Revenue growth 3Y-2.49%
Revenue growth 5Y-6.73%
Sales Q2Q%-23.84%
Revenue Next Year1.27%
Revenue Next 2Y5.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year92.9%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y126.3%
FCF growth 3YN/A
FCF growth 5Y-27.55%
OCF growth 1Y148.88%
OCF growth 3YN/A
OCF growth 5Y-11.65%